Gregory Norden, Director at Royalty Pharma plc (RPRX), sold 33,500 shares at $36.23 ($1.2M) on 2025-08-11, disclosed to the SEC on 2025-08-11.
Open-market sale of $1.2M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZTS | SELL | 2021-11-09 | $972K | — | Filing → |
| NSTG | SELL | 2020-12-09 | $1.2M | — | Filing → |
| NSTG | SELL | 2020-08-13 | $388K | — | Filing → |